作者: Janice M. Fiori , Roger D. Meyerhoff
关键词: Risk assessment 、 Mutagen 、 De minimis 、 Risk factor (computing) 、 Audit risk 、 Risk management 、 Risk analysis (engineering) 、 Risk analysis 、 Carcinogen 、 Medicine
摘要: Risk assessment processes for carcinogens are highly developed but risk mutagens not well established. In the pharmaceutical industry, associated with exposure to is tightly controlled. It desirable control also, in spite of greater uncertainty risk. this paper, a published cancer potency database used frame and support management decisions. A de minimis proposed decision matrix presented align available data approaches mutagens.